Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort

Published:2017-03-02 Issue:9 Volume:45 Page:1232-1243
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ma C.¹^ORCID,Fedorak R. N.²,Kaplan G. G.¹,Dieleman L. A.²,Devlin S. M.¹,Stern N.²,Kroeker K. I.²,Seow C. H.¹^ORCID,Leung Y.³,Novak K. L.¹,Halloran B. P.²,Huang V. W.²,Wong K.²,Blustein P. K.¹,Ghosh S.⁴,Panaccione R.¹

Affiliation:

1. Division of Gastroenterology; University of Calgary; Calgary Alberta Canada

2. Division of Gastroenterology; University of Alberta; Edmonton Alberta Canada

3. Division of Gastroenterology; University of British Columbia; Vancouver British Columbia Canada

4. University of Birmingham; Birmingham UK

Funder

Canadian Association of Gastroenterology

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14016/fullpdf

Reference29 articles.

1. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis;Hazlewood;Gastroenterology,2015

2. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

3. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

4. Certolizumab pegol for the treatment of Crohn's disease;Sandborn;N Engl J Med,2007

5. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial;Sandborn;Gut,2007

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to loss of response to advanced therapies in inflammatory bowel disease;World Journal of Gastroenterology;2024-06-14

2. Fibrostenosing Crohn’s Disease: Pathogenetic Mechanisms and New Therapeutic Horizons;International Journal of Molecular Sciences;2024-06-07

3. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU;Digestive and Liver Disease;2024-06

4. Genotype and clinical phenotype of children with Marfan syndrome in Southeastern Anatolia;European Journal of Pediatrics;2024-05-03

5. STEP-CD study: ustekinumab use in paediatric Crohn’s disease—a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN;European Journal of Pediatrics;2024-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3